Tag - medicine-4

 
 

MEDICINE 4

Japan Times
COMMENTARY / Japan
Jun 28, 2020
Japan's pragmatic approach to COVID-19 testing
At this point it is necessary to develop a stepwise approach from the end of the state of emergency to a final exit strategy.
Japan Times
WORLD / FOCUS
Jun 27, 2020
As U.S. coronavirus cases hit new high, questions abound over whether deaths will follow
The administration of U.S. President Donald Trump has highlighted an apparent disconnect between rising cases and declining mortality as proof the COVID-19 pandemic is under control.
Japan Times
WORLD / Science & Health
Jun 27, 2020
Heart, kidneys, pancreas: Scientists just starting to understand health effects of COVID-19
Besides respiratory issues, the virus that causes COVID-19 attacks many organ systems, in some cases causing catastrophic damage.
Japan Times
JAPAN / Science & Health
Jun 27, 2020
Daiichi Sankyo in talks with AstraZeneca on virus vaccine supply in Japan
Daiichi Sankyo Co. is in discussions to provide supplies of a potential coronavirus vaccine now being developed by AstraZeneca PLC and the University of Oxford for use in Japan.
Japan Times
WORLD / Science & Health
Jun 26, 2020
Africa's unsung army of women wage war on coronavirus
Front-line community health workers are often unpaid despite long being responsible for educating communities about safety and preventative practices.
Japan Times
JAPAN / Science & Health / EXPLAINER
Jun 26, 2020
What will it take to achieve virus herd immunity and how close is Japan?
Tests on randomly selected people in Tokyo, Miyagi and Osaka prefectures showed an extremely low infection rate in all three locations.
Japan Times
WORLD / Science & Health
Jun 26, 2020
Severe COVID-19 can damage the brain, preliminary study finds
A preliminary study of patients hospitalized with COVID-19 has found the disease can damage the brain, causing complications such as stroke, inflammation, psychosis and dementia-like symptoms in some severe cases.
Japan Times
JAPAN / Science & Health / EXPLAINER
Jun 25, 2020
The race to develop a COVID-19 vaccine, and Japan's place in it
With more than 140 coronavirus measures in development and 13 undergoing trials, hopes are being pinned on one being approved in the near future.
Japan Times
WORLD / Science & Health
Jun 25, 2020
Group finds manufacturing capacity for 4 billion doses of coronavirus vaccines
An influential foundation focused on preparation and response to epidemics that is backing nine potential coronavirus vaccines has identified manufacturers with capacity to produce four billion doses a year, the group's top manufacturing expert said.
Japan Times
JAPAN / Science & Health
Jun 24, 2020
Wanted: More COVID-19 patients in Japan ... for clinical trials
Japan has become a victim of its own success as slowing new infections have led to a shortage of patients to enroll in trials for treatments and vaccines.
Japan Times
JAPAN
Jun 24, 2020
The low-tech way that Japan managed to tackle the virus quickly
Experts contend that the existence of public health centers are one of the key reasons Japan was able to avoid an explosion in coronavirus cases.
Japan Times
BUSINESS / Companies
Jun 23, 2020
Gilead targets remdesivir supply for 2 million COVID-19 patients by year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, which is currently administered only intravenously.
Japan Times
BUSINESS / Companies
Jun 22, 2020
Japan drugmaker to tie up with universities to develop new test method for coronavirus
Japanese pharmaceutical company Shionogi & Co. said Monday that it will collaborate with universities in the country to put into practical use a new testing method for the novel coronavirus.
Japan Times
WORLD / Science & Health
Jun 22, 2020
Antibody levels in recovered COVID-19 patients decline quickly, research finds
The findings raise questions about the length of any immunity against the novel coronavirus.
Japan Times
JAPAN / Media / MEDIA MIX
Jun 20, 2020
Japan's essential care workers currently languish at the bottom of the health care pyramid
Caregiving companies are going out of business even as the demand for their services increases.
Japan Times
ASIA PACIFIC / Science & Health
Jun 20, 2020
Chinese vaccine may not be ready for sale until at least 2021
A coronavirus vaccine candidate China is developing may not be ready for sale until at least 2021, as researchers struggle to move into large-scale human trials in the country because of a lack of new infections, a senior company executive said.
Japan Times
ASIA PACIFIC / Science & Health / ANALYSIS
Jun 19, 2020
China's public health reforms may not prevent next virus
China's latest plans to overhaul its disease control system may not improve its ability to handle future virus outbreaks, according to some experts inside and outside the country.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?